How to Buy Ideaya Biosciences Stock
Ideaya Biosciences Inc
IDEAYA Biosciences, Inc. , a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
Ideaya Biosciences stock last closed at $18.18, up 6.44% from the previous day, and has decreased 51.64% in one year. It has overperformed other stocks in the Biotechnology industry by 0.26 percentage points. Ideaya Biosciences stock is currently +35.17% from its 52-week low of $13.45, and -59.07% from its 52-week high of $44.42.
As of Apr 21, 2025, there are 87.54M IDYA shares outstanding. The market capitalization of IDYA is $1.59B. In the last 24 hours, 1.36M IDYA shares were traded.
How to Buy Ideaya Biosciences Stock
Wondering how to invest in Ideaya Biosciences stock? Here's how.
- Decide where to buy Ideaya Biosciences stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Ideaya Biosciences stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your method of payment and add your info.
- Evaluate Ideaya Biosciences stock: The Ideaya Biosciences ticker symbol is IDYA. Is Ideaya Biosciences stock a good investment? Should you buy shares of IDYA? How do IDYA's underlying business fundamentals look? Do top analysts think Ideaya Biosciences is a good buy? Why has IDYA's stock price moved recently? (Hint: Our stock market analysis website can help you decide if IDYA is a good stock to buy).
- Execute your IDYA purchase: Decide if you will purchase IDYA shares at the current market price or use a limit order to buy IDYA stock at a specific price.
- Keep an eye on your IDYA position: Create a watchlist to the latest updates on your investment in Ideaya Biosciences shares.
Step 1: Decide where to buy Ideaya Biosciences stock
You need an online brokerage account to access the NASDAQ market and buy IDYA stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you are able to invest in IDYA stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new brokerage account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on the best stock market app, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of transferring funds into your new investment account.
Step 4: Evaluate Ideaya Biosciences stock
After you have figured out the best place to buy Ideaya Biosciences stock, it's important to analyze their stock prior to investing, so you actually understand the risk as well as the upside.
Ideaya Biosciences Metrics
Ideaya Biosciences Overview
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on IDYA's stock page.
What is the fair value of IDYA stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge IDYA's true value.
Using relative valuations metrics:
- IDYA may be undervalued based on its P/B ratio of 1.5x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation analysis on IDYA's stock here.
How do IDYA Financials look?
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the IDYA balance sheet.
- IDYA has a low debt to equity ratio of 0.06.
- There are more short-term assets than long-term liabilities on the IDYA balance sheet.
- Total IDYA debt is lower than 5 years ago, relative to shareholder equity.
- IDYA has $677.12M in cash and short term investments. This is enough to cover its annual cash burn of $251.44M.
- IDYA has cash burn of 251441000. It has enough cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- IDYA profit margin has gone down from -483% to -3,921.1% in the past year.
Is it a good time to buy IDYA stock, according to Wall Street analysts?
Out of 6 sell side analysts who monitor IDYA, the consensus analyst rating on IDYA is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest IDYA Analyst Ratings
David Dai, a bottom 5% analyst from UBS initiates coverage on IDYA with a strong buy rating and announces their IDYA price target of $50.00, on Oct 24, 2024.
You can dig deeper into what analysts are forecasting on the Ideaya Biosciences stock forecast page.
IDYA Trading Indicators
IDYA Performance Metrics
Last year, IDYA revenue was $7.00M. During the last four year, IDYA's revenue has grown by -22.63% per year. This was slower than the Biotechnology industry average of 44.31%.
Dig into IDYA's earnings and revenue performance here.
Latest Insiders Trades at IDYA
In the past 12 months, insiders at IDYA have bought more shares than they have sold.
Yujiro S. Hata, President and CEO of IDYA, was the latest IDYA insider to buy. They bought $250,012.16 worth of IDYA stock on Feb 18, 2025.
Dig into more about who owns IDYA shares here.
Can I rely on IDYA as an income stream?
No, Ideaya Biosciences doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your IDYA purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your IDYA position
Now that you own some IDYA shares, you'll want to stay up-to-date on your new shares.
Put IDYA on a watchlist to monitor your IDYA stock.
IDYA Feed
How to Buy Stock in Ideaya Biosciences
To reiterate, here are the 6 steps you need to take to buy Ideaya Biosciences stock right now:
- Decide where to buy Ideaya Biosciences stock
- Sign up for a brokerage account
- Fund your investment account
- Evaluate Ideaya Biosciences stock
- Execute your IDYA purchase
- Keep an eye on your IDYA position
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Ideaya Biosciences, get started below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.